These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15078100)

  • 1. Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
    Kwiek JJ; Haystead TA; Rudolph J
    Biochemistry; 2004 Apr; 43(15):4538-47. PubMed ID: 15078100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the redox cycle of human quinone reductase 2.
    Reybier K; Perio P; Ferry G; Bouajila J; Delagrange P; Boutin JA; Nepveu F
    Free Radic Res; 2011 Oct; 45(10):1184-95. PubMed ID: 21762045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new inhibitors of quinone reductase 2.
    Ferry G; Hecht S; Berger S; Moulharat N; Coge F; Guillaumet G; Leclerc V; Yous S; Delagrange P; Boutin JA
    Chem Biol Interact; 2010 Jul; 186(2):103-9. PubMed ID: 20399199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
    Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA
    Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of stopped flow to steady state parameters in the dimeric copper amine oxidase from Hansenula polymorpha and the role of zinc in inhibiting activity at alternate copper-containing subunits.
    Takahashi K; Klinman JP
    Biochemistry; 2006 Apr; 45(14):4683-94. PubMed ID: 16584203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinone reductase 2 substrate specificity and inhibition pharmacology.
    Boutin JA; Chatelain-Egger F; Vella F; Delagrange P; Ferry G
    Chem Biol Interact; 2005 Feb; 151(3):213-28. PubMed ID: 15733542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRH:quinone reductase 2: an enzyme of surprises and mysteries.
    Vella F; Ferry G; Delagrange P; Boutin JA
    Biochem Pharmacol; 2005 Dec; 71(1-2):1-12. PubMed ID: 16253210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate.
    Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G
    J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
    Cénas N; Lê KH; Terrier M; Lederer F
    Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
    Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
    Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a new type of NADPH-dependent quinone oxidoreductase (QOR2) from Escherichia coli.
    Kim IK; Yim HS; Kim MK; Kim DW; Kim YM; Cha SS; Kang SO
    J Mol Biol; 2008 May; 379(2):372-84. PubMed ID: 18455185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and reactivity of Candida albicans estrogen binding protein with steroid and other substrates.
    Buckman J; Miller SM
    Biochemistry; 1998 Oct; 37(40):14326-36. PubMed ID: 9760270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of quinone reductase 2 in complex with resveratrol.
    Buryanovskyy L; Fu Y; Boyd M; Ma Y; Hsieh TC; Wu JM; Zhang Z
    Biochemistry; 2004 Sep; 43(36):11417-26. PubMed ID: 15350128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular knock-down of quinone reductase 2: a laborious road to successful inhibition by RNA interference.
    Chomarat P; Cogé F; Guénin SP; Mailliet F; Vella F; Mallet C; Giraudet S; Nagel N; Leonce S; Ferry G; Delagrange P; Boutin JA
    Biochimie; 2007 Oct; 89(10):1264-75. PubMed ID: 17714848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of the L-ornithine transcarbamoylase from Pseudomonas savastanoi pv. phaseolicola that is resistant to the transition state analogue (R)-N delta-(N'-sulfodiaminophosphinyl)-L-ornithine.
    Templeton MD; Reinhardt LA; Collyer CA; Mitchell RE; Cleland WW
    Biochemistry; 2005 Mar; 44(11):4408-15. PubMed ID: 15766270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.
    Fu Y; Buryanovskyy L; Zhang Z
    Biochem Biophys Res Commun; 2005 Oct; 336(1):332-8. PubMed ID: 16129418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical phosphate transfer mechanism for the thiamin diphosphate- and FAD-dependent pyruvate oxidase from Lactobacillus plantarum. Kinetic coupling of intercofactor electron transfer with phosphate transfer to acetyl-thiamin diphosphate via a transient FAD semiquinone/hydroxyethyl-ThDP radical pair.
    Tittmann K; Wille G; Golbik R; Weidner A; Ghisla S; Hübner G
    Biochemistry; 2005 Oct; 44(40):13291-303. PubMed ID: 16201755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antimalarial drugs chloroquine and primaquine inhibit pyridoxal kinase, an essential enzyme for vitamin B6 production.
    Kimura T; Shirakawa R; Yaoita N; Hayashi T; Nagano K; Horiuchi H
    FEBS Lett; 2014 Oct; 588(20):3673-6. PubMed ID: 25157434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.
    Calamini B; Santarsiero BD; Boutin JA; Mesecar AD
    Biochem J; 2008 Jul; 413(1):81-91. PubMed ID: 18254726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel targets of quinoline drugs in the human purine binding proteome.
    Graves PR; Kwiek JJ; Fadden P; Ray R; Hardeman K; Coley AM; Foley M; Haystead TA
    Mol Pharmacol; 2002 Dec; 62(6):1364-72. PubMed ID: 12435804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.